Curcumin has neuroprotection effect on homocysteine rat model of Parkinson

Journal of Molecular Neuroscience

Volumn 47, Issue 2, 2012, Pages 234-242

  Mansouri, Zahra ^a   Sabetkasaei, Masoumeh ^a   Moradi, Fatemeh ^a   Masoudnia, Fatemeh ^a   Ataie, Amin ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

Curcumin; Homocysteine; Intracerebroventricular; Locomotor activity; Rat; Stress oxidative

Indexed keywords

CURCUMIN; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; IMMUNOHISTOLOGY; LOCOMOTION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BRAIN; CURCUMIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HOMOCYSTEINE; MALE; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84863862289     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9727-3     Document Type: Article

References (60)

1. Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30(2):85-94
2. Algaidi SA, Christie LA, Jenkinson AM, Whalley L, Riedel G, Platt B (2006) Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp Neurol 197(1):8-21 (Pubitemid 41817217)
3. Ataie A, Sabetkasaei M, Haghparast A, Moghaddam AH, Kazeminejad B (2010) Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat. Pharmacol Biochem Behav 96(4):378-385
4. Baydas G, Reiter RJ, Akbulut M, Tuzcu M, Tamer S (2005) Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels. Neuroscience 135(3):879-886 (Pubitemid 41407750)
5. Deveraux QL, Schendel SL, Reed JC (2001) Antiapoptotic proteins. The bcl-2 and inhibitor of apoptosis protein families. Cardiol Clin 19(1):57-74 (Pubitemid 32433916)
6. Eto K, Asada T, Arima K, Makifuchi T, Kimura H (2002) Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun 293(5):1485-1488 (Pubitemid 34681045)
7. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST (2000) Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study. Arch Neurol 57(6):824-830 (Pubitemid 30397184)
8. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES (2002) Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res 46(3):273-279 (Pubitemid 35300767)
9. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 53(6):1284-1291 (Pubitemid 29480089)
10. Gottfries CG, Lehmann W, Regland B (1998) Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease. J Neural Transm 105(8-9):773-786 (Pubitemid 28539829)
11. Ho PI, Ortiz D, Rogers E, Shea TB (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70(5):694-702 (Pubitemid 35397143)
12. Hoehn MM (1987) Parkinson's disease: progression and mortality. Adv Neurol 45:457-461
13. Jagatha B, Mythri RB, Vali S, Bharath MM (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic Biol Med 44(5):907-917
14. Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V (2005) Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology 26(4):701-719 (Pubitemid 41175903)
15. Kim WK, Pae YS (1996) Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 216(2):117-120
16. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4(6):327-332 (Pubitemid 2028596)
17. Krajewska M, Zapata JM, Meinhold-Heerlein I, Hedayat H, Monks A, Bettendorf H, Shabaik A, Bubendorf L, Kallioniemi OP, Kim H, Reifenberger G, Reed JC, Krajewski S (2002) Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia 4(2):129-140 (Pubitemid 34218681)
18. Kruman C II, Culmsee SL, Chan Y, Kruman Z, Guo LP, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20(18):6920-6926
19. Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, Buttner T, Woitalla D, Muller T (1998) Elevated plasma levels of homocysteine in Parkinson's disease. Eur Neurol 40(4):225-227 (Pubitemid 28526247)
20. Lee ES, Chen H, Soliman KF, Charlton CG (2005) Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology 26(3):361-371 (Pubitemid 40780013)
21. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94(11):5923-5928
22. Liu W, Fan Z, Han Y, Lu S, Zhang D, Bai X, Xu W, Li J, Wang H (2011) Curcumin attenuates peroxynitrite-induced neurotoxicity in spiral ganglion neurons. Neurotoxicology 32(1):150-157
23. Lotharius J, Brundin P (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3(12):932-942
24. Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautschy SA, Cole GM (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun Nterminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29(28):9078-9089
25. Maler JM, Seifert W, Huther G, Wiltfang J, Ruther E, Kornhuber J, Bleich S (2003) Homocysteine induces cell death of rat astrocytes in vitro. Neurosci Lett 347(2):85-88 (Pubitemid 36836222)
26. Mattson MP, Duan W (1999) "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neuro-degenerative disorders. J Neurosci Res 58(1):152-166 (Pubitemid 29463701)
27. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26(3):137-146 (Pubitemid 36183675)
28. Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann N Y Acad Sci 893:154-175 (Pubitemid 30038074)
29. Mooney SM, Miller MW (2000) Expression of bcl-2, bax, and caspase-3 in the brain of the developing rat. Brain Res Dev Brain Res 123(2):103-117
30. Muller T, Werne B, Fowler B, Kuhn W (1999) Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet 354(9173):126-127 (Pubitemid 29313150)
31. Muller T, Woitalla D, Hauptmann B, Fowler B, Kuhn W (2001) Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease. Neurosci Lett 308(1):54-56 (Pubitemid 32607679)
32. Muller T, Woitalla D, Fowler B, Kuhn W (2002) 3-OMD and homocysteine plasma levels in parkinsonian patients. J Neural Transm 109(2):175-179 (Pubitemid 34185663)
33. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, Nygaard HA, Smith AD (2005) Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol 58(6):847-857 (Pubitemid 41746874)
34. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74(4):609-619 (Pubitemid 23259742)
35. Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501
36. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143-183
37. Park SY, Kim HS, Cho EK, Kwon BY, Phark S, Hwang KW, Sul D (2008) Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol 46(8):2881-2887
38. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5th Edn. Elsevier/Academic Press, San Diego
39. Pompeiano M, Blaschke AJ, Flavell RA, Srinivasan A, Chun J (2000) Decreased apoptosis in proliferative and postmitotic regions of the caspase 3-deficient embryonic central nervous system. J Comp Neurol 423(1):1-12 (Pubitemid 30407785)
40. Quinn CT, Griener JC, Bottiglieri T, Arning E, Winick NJ (2004) Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid. J Pediatr Hematol Oncol 26(6):386-388
41. Rajeswari A, Sabesan M (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16(2):96-99
42. Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545(1):51-64
43. Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG (1997) Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol 26(4):301-307 (Pubitemid 27390761)
44. Reutens S, Sachdev P (2002) Homocysteine in neuropsychiatric disorders of the elderly. Int J Geriatr Psychiatry 17(9):859-864
45. Roghani M, Behzadi G (2001) Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Brain Res 892(1):211-217 (Pubitemid 32126584)
46. Shen SQ, Zhang Y, Xiang JJ, Xiong CL (2007) Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 13(13):1953-1961 (Pubitemid 46758857)
47. Streck EL, Bavaresco CS, Netto CA, Wyse AT (2004) Chronic hyper-homocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav Brain Res 153(2):377-381 (Pubitemid 38953111)
48. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuro-report 5(18):2529-2533
49. Sumanont Y, Murakami Y, Tohda M, Vajragupta O, Watanabe H, Matsumoto K (2007) Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. Biol Pharm Bull 30(9):1732-1739 (Pubitemid 47403254)
50. Sun F, Akazawa S, Sugahara K, Kamihira S, Kawasaki E, Eguchi K, Koji T (2002) Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and Bcl-2. Arch Histol Cytol 65(2):145-157 (Pubitemid 34857550)
51. Thiyagarajan M, Sharma SS (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74(8):969-985 (Pubitemid 37522132)
52. Thomas P, Wang YJ, Zhong JH, Kosaraju S, O'Callaghan NJ, Zhou XF, Fenech M (2009) Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease. Mutat Res 661(1-2):25-34
53. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267(5203):1456-1462
54. Watson RE, Craven NM, Kang S, Jones CJ, Kielty CM, Griffiths CE (2001) A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. J Invest Dermatol 116(5):672-678 (Pubitemid 32467644)
55. Wilson I, Gamble M (2002) The hematoxylin and eosin. In: Bancroft JD, Gamble (eds) Theory and practice of histological techniques, 5th edn. Churchill Livingstone, London, pp 125-138
56. Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306 (Pubitemid 11219226)
57. Yanai Y, Shibasaki T, Kohno N, Mitsui T, Nakajima H (1983) Concentrations of sulfur-containing free amino acids in lumbar cerebrospinal fluid from patients with consciousness disturbances. Acta Neurol Scand 68(6):386-393 (Pubitemid 14214459)
58. Yang S, Zhang D, Yang Z, Hu X, Qian S, Liu J, Wilson B, Block M, Hong JS (2008) Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res 33(10):2044-2053
59. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 39(10):1119-1125 (Pubitemid 41358566)
60. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajima S (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276(38):35867-35874